Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605460979> ?p ?o ?g. }
- W2605460979 abstract "Hepatic sinusoidal obstruction syndrome (SOS) during treatment of childhood acute lymphoblastic leukemia (ALL) has mainly been associated with 6-thioguanine. The occurrence of several SOS cases after the introduction of extended pegylated asparaginase (PEG-asparaginase) therapy in the Nordic Society of Paediatric Haematology and Oncology (NOPHO) ALL2008 protocol led us to hypothesize that PEG-asparaginase, combined with other drugs, may trigger SOS during 6-thioguanine-free maintenance therapy.In children with ALL treated in Denmark according to the NOPHO ALL2008 protocol, we investigated the risk of SOS during methotrexate (MTX)/6-mercaptopurine (6MP) maintenance therapy that included PEG-asparaginase until week 33 (randomized to two- vs. six-week intervals), as well as alternating high-dose MTX or vincristine/dexamethasone pulses every four weeks.Among 130 children receiving PEG-asparaginase biweekly, 29 developed SOS (≥2 criteria: hyperbilirubinemia, hepatomegaly, ascites, weight gain ≥2.5%, unexplained thrombocytopenia <75 × 109 l-1 ) at a median of 30 days (interquartile range [IQR]: 17-66) into maintenance (cumulative incidence: 27%). SOS cases fulfilling one, two, or three Ponte di Legno criteria were classified as possible (n = 2), probable (n = 8), or verified (n = 19) SOS, respectively. Twenty-six cases (90%) occurred during PEG-asparaginase treatment, including 21 (81%) within 14 days from the last chemotherapy pulse compared with the subsequent 14 days (P = 0.0025). Cytotoxic 6MP metabolites were significantly higher on PEG-asparaginase compared to after its discontinuation. Time-dependent Cox regression analysis showed increased SOS hazard ratio (HR) for erythrocyte levels of methylated 6MP metabolites (HR: 1.09 per 1,000 nmol/mmol hemoglobin increase, 95% confidence interval: 1.05-1.14). Six-week PEG-asparaginase intervals significantly reduced SOS-specific hazards (P < 0.01).PEG-asparaginase increases cytotoxic 6MP metabolite levels and risk of SOS, potentially interacting with other chemotherapy pulses." @default.
- W2605460979 created "2017-04-28" @default.
- W2605460979 creator A5001744506 @default.
- W2605460979 creator A5007917870 @default.
- W2605460979 creator A5017466426 @default.
- W2605460979 creator A5022352827 @default.
- W2605460979 creator A5038489096 @default.
- W2605460979 creator A5047221635 @default.
- W2605460979 creator A5050124369 @default.
- W2605460979 creator A5055408302 @default.
- W2605460979 creator A5060048770 @default.
- W2605460979 creator A5063115909 @default.
- W2605460979 creator A5071720008 @default.
- W2605460979 creator A5074845542 @default.
- W2605460979 creator A5078889687 @default.
- W2605460979 date "2017-04-19" @default.
- W2605460979 modified "2023-10-11" @default.
- W2605460979 title "Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites" @default.
- W2605460979 cites W1606371069 @default.
- W2605460979 cites W1966771497 @default.
- W2605460979 cites W1966879127 @default.
- W2605460979 cites W1968262401 @default.
- W2605460979 cites W1972756160 @default.
- W2605460979 cites W1974788567 @default.
- W2605460979 cites W1975903555 @default.
- W2605460979 cites W1978042853 @default.
- W2605460979 cites W1983279908 @default.
- W2605460979 cites W1991218671 @default.
- W2605460979 cites W1992750424 @default.
- W2605460979 cites W1993379102 @default.
- W2605460979 cites W1993783426 @default.
- W2605460979 cites W2016756549 @default.
- W2605460979 cites W2035029649 @default.
- W2605460979 cites W2038604255 @default.
- W2605460979 cites W2044141667 @default.
- W2605460979 cites W2061069132 @default.
- W2605460979 cites W2076057372 @default.
- W2605460979 cites W2079689830 @default.
- W2605460979 cites W2082217912 @default.
- W2605460979 cites W2082600916 @default.
- W2605460979 cites W2091614598 @default.
- W2605460979 cites W2100928838 @default.
- W2605460979 cites W2104428172 @default.
- W2605460979 cites W2118755887 @default.
- W2605460979 cites W2122712927 @default.
- W2605460979 cites W2125277492 @default.
- W2605460979 cites W2133589701 @default.
- W2605460979 cites W2149350612 @default.
- W2605460979 cites W2151348405 @default.
- W2605460979 cites W2158585848 @default.
- W2605460979 cites W2172173460 @default.
- W2605460979 cites W2183168575 @default.
- W2605460979 cites W2410554704 @default.
- W2605460979 cites W2480796907 @default.
- W2605460979 cites W426270985 @default.
- W2605460979 doi "https://doi.org/10.1002/pbc.26519" @default.
- W2605460979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28423235" @default.
- W2605460979 hasPublicationYear "2017" @default.
- W2605460979 type Work @default.
- W2605460979 sameAs 2605460979 @default.
- W2605460979 citedByCount "20" @default.
- W2605460979 countsByYear W26054609792017 @default.
- W2605460979 countsByYear W26054609792018 @default.
- W2605460979 countsByYear W26054609792019 @default.
- W2605460979 countsByYear W26054609792020 @default.
- W2605460979 countsByYear W26054609792021 @default.
- W2605460979 countsByYear W26054609792022 @default.
- W2605460979 countsByYear W26054609792023 @default.
- W2605460979 crossrefType "journal-article" @default.
- W2605460979 hasAuthorship W2605460979A5001744506 @default.
- W2605460979 hasAuthorship W2605460979A5007917870 @default.
- W2605460979 hasAuthorship W2605460979A5017466426 @default.
- W2605460979 hasAuthorship W2605460979A5022352827 @default.
- W2605460979 hasAuthorship W2605460979A5038489096 @default.
- W2605460979 hasAuthorship W2605460979A5047221635 @default.
- W2605460979 hasAuthorship W2605460979A5050124369 @default.
- W2605460979 hasAuthorship W2605460979A5055408302 @default.
- W2605460979 hasAuthorship W2605460979A5060048770 @default.
- W2605460979 hasAuthorship W2605460979A5063115909 @default.
- W2605460979 hasAuthorship W2605460979A5071720008 @default.
- W2605460979 hasAuthorship W2605460979A5074845542 @default.
- W2605460979 hasAuthorship W2605460979A5078889687 @default.
- W2605460979 hasConcept C119060515 @default.
- W2605460979 hasConcept C126322002 @default.
- W2605460979 hasConcept C207103383 @default.
- W2605460979 hasConcept C2776694085 @default.
- W2605460979 hasConcept C2776755627 @default.
- W2605460979 hasConcept C2776760755 @default.
- W2605460979 hasConcept C2777173762 @default.
- W2605460979 hasConcept C2778283404 @default.
- W2605460979 hasConcept C2778461978 @default.
- W2605460979 hasConcept C2778715236 @default.
- W2605460979 hasConcept C2778720950 @default.
- W2605460979 hasConcept C2778904437 @default.
- W2605460979 hasConcept C2779134260 @default.
- W2605460979 hasConcept C2779429289 @default.
- W2605460979 hasConcept C2781059491 @default.
- W2605460979 hasConcept C2781107101 @default.
- W2605460979 hasConcept C2909962599 @default.
- W2605460979 hasConcept C44249647 @default.